麻豆传媒

BOSTON-Adverse event reports from the FDA suggest that Crestor is more likely to cause muscle and kidney damage than other major statins (Lipitor, Pravachol or Zocor), researchers here reported in the journal Circulation.

ORLANDO-Cardiologists report that aggressive cholesterol-lowering to new super low target levels of LDL is associated with a 22% reduction in risk of heart attack, stroke, cardiac arrest and death from heart disease for patients with stable coronary disease. The reduction to a mean of 77 mg/dL compared with standard cholesterol-lowering therapy that aims to reduce LDL to about 100 mg/dL. In addition, stroke risk was reduced by 25% compared with risk in patients treated to the recommended target of 100 mg/dL.

Three servings of psyllium (Metamucil) per day reduced the low-density lipoprotein (LDL) levels of patients on a statin drug by an additional 6%, roughly the same reduction achieved by doubling the statin dose, according to research presented at the American Heart Association 2004 Scientific Sessions.